The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients

Similar Items

• Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial.
  by: Carla Guerriero, et al.
  Published: (2011-05-01)
• CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury, a nested randomised, placebo-controlled trial.
  by: P Perel, et al.
  Published: (2012-03-01)
• Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation
  by: Perel Pablo, et al.
  Published: (2010-02-01)
• Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial
  by: P Perel, et al.
  Published: (2013-06-01)
• Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial
  by: Ker Katharine, et al.
  Published: (2012-03-01)